|Articles|April 9, 2023
- Pharmaceutical Executive: April 2023
- Volume 43
- Issue 4
Pharmaceutical Executive, April 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Unwavering Focusabout 3 years ago
A Brand Game-Changer? TikTok and Pharma Marketingabout 3 years ago
Tough—But Rewarding: The Evolution of the Chief Diversity Officerabout 3 years ago
Does the Biotech Sector Have Reason to Be Optimistic?about 3 years ago
Kudos and Hurdles for Industry, FDA in Tackling Rare Diseasesabout 3 years ago
The Payer Value Deficit in Orphan Drugsabout 3 years ago
Seizing On Asia’s Opportune Market for Novel Vaccinesabout 3 years ago
European Policy Called Out as Threat to Drug Trade and InvestmentAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
2
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
3
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
4
FDA's Timeline for DTC Prescription Drug Ad Oversight
5